Navigation Links
PhUSE Working Group Active in Developing Standard Analysis Scripts
Date:1/12/2014

Silver Spring, Maryland (PRWEB) January 12, 2014

The PhUSE Computational Science Symposium Working Group on the development of Standard Scripts has been active in 2013 in pursuing its goal to begin standardizing clinical data analyses across the Pharmaceutical and Biotech industries. The working group comprises members from industry and academia, and receives input from the US Food and Drug Administration.

In October, the Working Group announced the release of its first white paper, providing advice on Central Tendency Analyses with a focus on Safety. The white paper release provided recommended standard tables and figures for measures of central tendency for a common set of safety measurements.

The authors of the white paper gave insight into the value of standard analysis scripts, stating that "Development of standard Tables, Figures, and Listings (TFLs) and associated analyses will lead to improved standardization from collection through data storage … the development of standard TFLs will also lead to improved product lifecycle management by ensuring reviewers receive the desired analyses for the consistent and efficient evaluation of patient safety and drug effectiveness."

The white paper on Central Tendency Analyses will be used as basis for PhUSE's first ever "Script-athon," to be held at the PhUSE Computational Sciences Symposium, in March 2014, in Silver Spring, Maryland, USA. The Script-athon will challenge programmers to collaborate to create standard scripts using code languages such as SAS and R. Targets for standard analysis and reporting scripts will be selected from the white paper. PhUSE supports an open and collaborative environment, and the outputs of the Script-athon will be stored in the PhUSE Standard Scripts working group code repository.

In addition to hosting the Script-athon, the working group will continue to focus on the creation of further white papers in 2014. The working group is keen to engage new voices from industry and academia to contribute to this work.

The important work conducted in 2013 is "…connected to strategic goal that PhUSE becomes the industry voice to regulatory agencies and standards organizations," said Mary Nilsson, industry co-lead of the Standard Scripts working group.

ABOUT PhUSE
PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical data science. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and clinical data scientists.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11479174.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
2. PhUSE Annual Conference to focus on Patient Centricity
3. Moffitt Cancer Center researchers working at frontiers of melanoma research
4. Doctors cite concern for patients, colleagues top motives for working sick
5. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
6. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
7. New Home Energy Savings Device Poised to Help Thousands Succeed Working from Home
8. Why current strategies for fighting obesity are not working
9. New Yorks Trans-Fat Ban Is Working: Study
10. Working toward an AIDS-free generation
11. Tumor cells inner workings predict cancer progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: